|
HESI Human health and Safety |
|
Enduring |
|
$0.00 |
|
Regulatory guidance: Introduction |
|
Enduring |
|
$25.00 |
|
Immune-related adverse events (clinical) |
|
Enduring |
|
$25.00 |
|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Quantitative systems pharmacology/ toxicology modeling for IO therapies |
|
Enduring |
|
$25.00 |
|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Cytokine Release Syndrome |
|
Enduring |
|
$25.00 |
|
Immuno-oncology |
|
Enduring |
|
$25.00 |
|
Cancer Immunotherapies |
|
Enduring |
|
$350.00 |
|
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.) |
|
Enduring |
|
$25.00 |
|
Basic principles of toxicology, toxicology of the immune system, relevance to immunosafety |
|
Enduring |
|
$25.00 |
|
Animal models and species differences (immune system) |
|
Enduring |
|
$25.00 |
|
Diversity of immune responses (impact of age, sex, pregnancy, co-morbidities, etc.) |
|
Enduring |
|
$25.00 |
|
Neurotoxicity across Cancer Modalities |
|
Enduring |
|
$25.00 |
|
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Facebook
Twitter
LinkedIn
Forward